Bonitas Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 09-12-2024
- Satisfied Charges ₹ 2.00 M
as on 09-12-2024
- Revenue 6.60%
(FY 2022)
- Profit 70.71%
(FY 2022)
- Ebitda 117.49%
(FY 2022)
- Net Worth 10.86%
(FY 2022)
- Total Assets -16.88%
(FY 2022)
About Bonitas Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Arora, Gagan Arora, Puja Arora, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232DL2006PTC156052
- Company No.
156052
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bonitas Life Sciences Private Limited offer?
Bonitas Life Sciences Private Limited offers a wide range of products and services, including Anti Ulcer Drugs, Rabeprazole Sodium & Levosulpiride capsules, Herbal Body Care Cosmetics, Herbal Foot Cream, Antibiotic Tablets & Capsules, Azithromycin Tablets, Immunization & Vaccination Drugs, Rabies Vaccine, Nutraceuticals, Dietary Supplements.
Who are the key members and board of directors at Bonitas Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Arora  | Director | 30-Nov-2006 | Current |
| Gagan Arora | Director | 30-Nov-2006 | Current |
| Puja Arora | Director | 10-Apr-2015 | Current |
| Vinita Arora | Director | 10-Apr-2015 | Current |
Financial Performance of Bonitas Life Sciences.
Bonitas Life Sciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.6% increase. The company also saw a substantial improvement in profitability, with a 70.71% increase in profit. The company's net worth Soared by an impressive increase of 10.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bonitas Life Sciences?
In 2021, Bonitas Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jun 2018 | ₹2.50 M | Open |
Ing Vysya Bank Limited Creation Date: 15 May 2012 | ₹2.00 M | Satisfied |
How Many Employees Work at Bonitas Life Sciences?
Unlock and access historical data on people associated with Bonitas Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bonitas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bonitas Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
